Eli Lilly Corp. buy UBS Group AG
Start price
24.05.23
/
50%
€397.00
Target price
24.05.24
€462.89
Performance (%)
88.34%
End price
25.05.24
€747.70
Summary
This prediction ended on 25.05.24 with a price of €747.70. With a performance of 88.34% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. A total of €4.48 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 4.486% | 4.486% | 19.612% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at UBS Group AG from $447.00 to $498.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Eli Lilly Corp.
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€557.00
20.10.23
20.10.23
€670.67
20.10.24
20.10.24
51.40%
21.10.24
21.10.24
